Vision Capital Management
ABBV icon

Vision Capital Management’s AbbVie ABBV Stock Holding History

Vision Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$501K Sell
1,915
-50
-3% -$12.8K 0.06% 109
2026
Q2 		$494K Hold
1,965
– – 0.06% 110
2026
Q1 		$427K Hold
1,965
– – 0.05% 112
2025
Q4 		$449K Hold
1,965
– – 0.05% 107
2025
Q3 		$455K Sell
1,965
-149
-7% -$30.3K 0.06% 104
2025
Q2 		$392K Buy
2,114
+627
+42% +$117K 0.05% 107
2025
Q1 		$312K Sell
1,487
-627
-30% -$122K 0.04% 112
2024
Q4 		$376K Hold
2,114
– – 0.06% 104
2024
Q3 		$417K Buy
+2,114
New +$395K 0.06% 101
2019
Q1 		– Sell
-48,863
Closed -$4.5M – 81
2018
Q4 		$4.5M Buy
48,863
+503
+1% +$44.2K 1.42% 23
2018
Q3 		$4.57M Sell
48,360
-230
-0.5% -$21.8K 1.24% 30
2018
Q2 		$4.5M Sell
48,590
-32
-0.1% -$3.12K 1.31% 26
2018
Q1 		$4.6M Sell
48,622
-1,832
-4% -$201K 1.36% 24
2017
Q4 		$4.88M Sell
50,454
-886
-2% -$83.5K 1.42% 22
2017
Q3 		$4.56M Sell
51,340
-1,218
-2% -$92.7K 1.45% 23
2017
Q2 		$3.81M Sell
52,558
-12,463
-19% -$838K 1.31% 29
2017
Q1 		$4.24M Sell
65,021
-3,539
-5% -$222K 1.52% 21
2016
Q4 		$4.29M Sell
68,560
-575
-0.8% -$35.1K 1.68% 23
2016
Q3 		$4.36M Buy
69,135
+1,842
+3% +$119K 1.83% 18
2016
Q2 		$4.17M Sell
67,293
-67,136
-50% -$4.09M 1.76% 19
2016
Q1 		$7.68M Buy
134,429
+3,750
+3% +$209K 1.87% 22
2015
Q4 		$7.74M Sell
130,679
-87,722
-40% -$5.05M 1.77% 28
2015
Q3 		$11.9M Sell
218,401
-5,374
-2% -$350K 2.66% 13
2015
Q2 		$15M Sell
223,775
-61,438
-22% -$4.01M 2.8% 8
2015
Q1 		$16.7M Buy
285,213
+110,553
+63% +$6.68M 2.5% 21
2014
Q4 		$11.4M Buy
+174,660
New +$11M 1.32% 40

Other funds holding ABBV

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Vision Capital Management's ABBV Position: Q3 2026 in Review

Vision Capital Management reduced its AbbVie (ABBV) stake by 2.5% in Q3 2026, selling an estimated $12.8K and leaving 1,915 shares worth $501K. The position accounts for 0.06% of the portfolio, ranked #109.

Vision Capital Management first reported a position in ABBV in Q4 2014 and has held it in 26 quarters since. The position peaked at $16.7M in Q1 2015. 2,418 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Vision Capital Management held 1,915 shares of AbbVie worth $501K as of Q3 2026.
  • Vision Capital Management sold 50 AbbVie shares in Q3 2026, an estimated $12.8K.
  • AbbVie made up 0.06% of Vision Capital Management's portfolio in Q3 2026, its #109 holding.
  • Vision Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 26 quarters since.
  • Vision Capital Management's AbbVie position peaked at $16.7M in Q1 2015.
  • 2,418 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vision Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.